Live from the NIH registry
Studies recruiting near Little Rock right now
Top 25 of 505 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: AstraZeneca
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Medical Investigations — Little Rock, Arkansas (4.1 mi)
· Sponsor: Medtronic MiniMed, Inc.
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
Malignant Solid Neoplasm
N/A
Interventional 1,020 participants sought
CARTI Cancer Center — Little Rock, Arkansas (4.1 mi)
· Sponsor: SWOG Cancer Research Network
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: SWOG Cancer Research Network
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome
N/A
Interventional 1,040 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: University of Calgary
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Parkinson Disease
Phase 2
Interventional 150 participants sought
University of Arkansas for Medical Sciences (Site #208) — Little Rock, Arkansas (4.1 mi)
· Sponsor: Appello Pharmaceuticals, Inc.
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Lymphatic Malformation
Phase 2
Interventional 38 participants sought
Arkansas Children's Hospital/UAMS — Little Rock, Arkansas (4.1 mi)
· Sponsor: Protara Therapeutics
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 641 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Janssen Research & Development, LLC
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Applied Research Center of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Rejoni Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Preferred Research Partners /ID# 270389 — Little Rock, Arkansas (4.1 mi)
· Sponsor: AbbVie
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
Endocervical Cancer
N/A
Interventional 20 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: University of Arkansas
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
University of Arkansas Winthrop P. Rockefeller Cancer Institute — Little Rock, Arkansas (4.1 mi)
· Sponsor: Context Therapeutics Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Arkansas Cardiology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Duke University
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis, Atopic
Phase 2
Interventional 280 participants sought
Dermatology Trial Associates, Inc — Bryant, Arkansas (11.7 mi)
· Sponsor: Apollo Therapeutics Ltd
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Neurogenic Detrusor Overactivity
Phase 2, Phase 3
Interventional 71 participants sought
Arkansas Childrens Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Urovant Sciences GmbH
A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures
Epilepsy, Generalized, Epilepsy, Absence
Phase 2
Interventional 12 participants sought
Clinical Trials, Inc. (CTI) — Little Rock, Arkansas (4.1 mi)
· Sponsor: NeuroPro Therapeutics, Inc.
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Carotid Artery Calcification, Carotid Artery Diseases
N/A
Interventional 185 participants sought
Arkansas Heart Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Shockwave Medical, Inc.
Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents
Pharmacokinetics After Oral Intake
Phase 1
Interventional 12 participants sought
Medical facility — Little Rock, Arkansas (4.1 mi)
· Sponsor: Iterum Therapeutics, International Limited
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
Phase 3
Interventional 800 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Non-Muscle Invasive Bladder Neoplasms
N/A
Observational 150 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Janssen Research & Development, LLC
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Proton Center of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Proton Collaborative Group